Abstract:Abstract Background: Influenza virus matrix protein M1 is encoded by viral RNA fragment 7 and is the most abundant protein in virus particles. M1 is expressed in the late stages of viral replication and exerts functionality by inhibiting viral transcription. The M1 protein sequence is an attractive target for antibody drugs. Methods: The M1 protein sequence was amplified by RT-PCR using cDNA from the H5N1 virus as a template; the M1 protein was then expressed and purified. A human strain, high affinity, and single chain antibody (HuScFv) against M1 protein was obtained by phage antibody library screening using M1 as an antigen. A recombinant TAT-HuScFv protein was expressed by fusion with the TAT protein transduction domain (PTD) gene of HIV to prepare a human intracellular antibody against avian influenza virus. The differences between HuScFv and TAT-HUScFv were verified by various experiments and the amino acid binding site of the M1 protein was determined. Results: The M1 protein of H5N1, HuScFv, and TAT-HuScFv, were successfully purified and expressed by and in E. coli . Further analysis demonstrated that TAT-HuScFv inhibited the hemagglutination activity of the 300TCID 50 H1N1 virus, thus providing preliminary validation of the universality of the antibody. After two rounds of M1 protein decomposition, the TAT-HuScFv antigen binding site was identified as Alanine (A) at position 239. Collectively, our data describe a recombinant antibody with high binding activity against the conserved sequences of avian influenza viruses. This intracellular recombinant antibody blocked the M1 protein that infected intracellular viruses, thus inhibiting the replication and reproduction of H5N1 viruses. Conclusion: Recombinant HuScFv was successfully identified using the Tomlinson (I+J) phage antibody library and successfully linked to the TAT protein transductive domain of the HIV virus. Compared with the HuScFv, the addition of the TAT peptide improved its ability to penetrate the cell membrane. A definite amino acid binding site was identified after the decomposition of M1 protein, thus providing a target and reference for the development of antibody drugs and the study of new drugs.

Immunological study of HA1 domain of hemagglutinin of influenza H5N1 virus

Identification and Analysis of B Cell Epitopes of Hemagglutinin of H1N1 Influenza Virus.

A Critical HA1 Neutralizing Domain of H5N1 Influenza in an Optimal Conformation Induces Strong Cross-Protection

Identification and Structural Characterization of a Broadly Neutralizing Antibody Targeting a Novel Conserved Epitope on the Influenza Virus H5N1 Hemagglutinin

Generation and Characterization of Monoclonal Antibodies Against the Hemagglutinin of H3N2 Influenza A Viruses.

Comparing the Antibody Responses Against Recombinant Hemagglutinin Proteins of Avian Influenza A (H5N1) Virus Expressed in Insect Cells and Bacteria

Analysis of epitopes on HA of H1 subtype influenza virus using monoclonal antibodies

An epitope on the stem region of hemagglutinin of H1N1 influenza A virus recognized by neutralizing monoclonal antibody.

Production of Influenza Virus HA1 Harboring Native-Like Epitopes by Pichia Pastoris.

Preparation and characterization of mouse-derived monoclonal antibodies against the hemagglutinin of the H1N1 influenza virus

Prokaryotic Expression and Immunogenicity of HA1 Protein of Avian Influenza Virus

Identification and structural definition of H5-specific CTL epitopes restricted by HLA-A*0201 derived from the H5N1 subtype of influenza A viruses.

A Human Antibody Recognizing a Conserved Epitope of H5 Hemagglutinin Broadly Neutralizes Highly Pathogenic Avian Influenza H5N1 Viruses

Purification and Crystallization of Hemagglutinin Expressed on the Cellular Membrane Originated from Avian Influenza Virus H5N1

Characterization of Neutralizing Monoclonal Antibodies and Identification of a Novel Conserved C-Terminal Linear Epitope on the Hemagglutinin Protein of the H9N2 Avian Influenza Virus

Self-Assembling Nanoparticle Hemagglutinin Influenza Vaccines Induce High Antibody Response

Conserved Stem Fragment from H3 Influenza Hemagglutinin Elicits Cross-Clade Neutralizing Antibodies Through Stalk-Targeted Blocking of Conformational Change During Membrane Fusion.

Prokaryotic Expression and Purification of HA1 and HA2 Polypeptides for Serological Analysis of the 2009 Pandemic H1N1 Influenza Virus.

An Intracellular Human Single Chain Antibody to Matrix Protein (M1) of H5N1 Virus

A Recombinant Protein Containing Highly Conserved Hemagglutinin Residues 81-122 of Influenza H5N1 Induces Strong Humoral and Mucosal Immune Responses.

Identification of Linear Peptide Immunogens with Verified Broad-spectrum Immunogenicity from the Conserved Regions within the Hemagglutinin Stem Domain of H1N1 Influenza Virus